Position in A
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$24,859,134
+$589,943 QoQ
Shares Held
187,150
-12.1% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#130
of 1,112 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 11%
Shared 89%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ceredex Value Advisors LLC holds $73,328,675 across 3 Diagnostics & Research names. A ranks #2 (33.9% of the industry book) .
All Filings in A
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,859,134 | 187,150 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $24,269,191 | 212,925 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $20,451,320 | 150,300 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $24,386,500 | 190,000 | Shares | Other | 2025-11-14 | |
| 2022-06-30 | $85,867,146 | 722,970 | Shares | Other | 2022-08-03 | |
| 2022-03-31 | $88,335,568 | 667,540 | Shares | Other | 2022-05-05 | |
| 2021-06-30 | $86,757,079 | 586,950 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $109,340,400 | 860,000 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $106,866,722 | 901,905 | Shares | Other | 2021-02-05 | |
| 2020-09-30 | $152,424,648 | 1,510,052 | Shares | Other | 2020-11-09 | |
| 2020-06-30 | $133,626,750 | 1,512,128 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $70,581,510 | 985,500 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||